Flag of the European Union EU Clinical Trials Register Help

Clinical trials for MD

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44339   clinical trials with a EudraCT protocol, of which   7369   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    895 result(s) found for: MD. Displaying page 1 of 45.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2011-001888-51 Sponsor Protocol Number: 27109640 Start Date*: 2011-09-12
    Sponsor Name:Inpharm
    Full Title:
    Medical condition: low back pain
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-000813-39 Sponsor Protocol Number: H7T-MC-TABL Start Date*: 2006-11-27
    Sponsor Name:Eli Lilly and Company
    Full Title: Prasugrel in comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation (PRINCIPLE) - TIMI 44
    Medical condition: subjects undergoing elective cardiac catheterization with planned percutaneous coronary intervention (PCI) with coronary stenting.
    Disease: Version SOC Term Classification Code Term Level
    8.1 10023031 Ischemia coronary artery origin LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2006-002618-37 Sponsor Protocol Number: H7T-MC-TABN Start Date*: 2006-12-28
    Sponsor Name:Eli Lilly and Company
    Full Title: A Randomized, Double-Blind, Cross-Over Study Comparing the Pharmacodynamic Response in Subjects with Acute Coronary Syndrome Receiving 14 Days 10-mg Maintenance Dose Prasugrel (LY640315) versus 14 ...
    Medical condition: subjects with acute coronary syndrome
    Disease: Version SOC Term Classification Code Term Level
    8.1 10051592 Acute coronary syndrome LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2010-020939-40 Sponsor Protocol Number: MD-Neo-Pilot Start Date*: 2010-07-28
    Sponsor Name:Medizinische Universität Wien,Univ.Klinik f.Kinder-u.Jugendheilkunde
    Full Title: Pilot Trial: Feasibility of Microdialysis for Pharmacokinetic Studies in Neonatal Patients
    Medical condition: The present pilot study intends to establish the logistics of MD measurements of antibiotics in subcutaneous tissue of neonatal intensive care patients. Antibiotic serum levels will be measured in ...
    Disease:
    Population Age: Preterm newborn infants, Newborns, Under 18 Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2011-004064-29 Sponsor Protocol Number: CS747S-B-U4003 Start Date*: 2012-06-11
    Sponsor Name:Daiichi Sankyo, Inc.
    Full Title: A PHARMACODYNAMIC EVALUATION OF SWITCHING FROM TICAGRELOR TO PRASUGREL IN SUBJECTS WITH STABLE CORONARY ARTERY DISEASE: 2ND SWITCHING ANTIPLATELET AGENTS (SWAP 2)
    Medical condition: Stable Coronary Artery Disease
    Disease: Version SOC Term Classification Code Term Level
    14.1 10007541 - Cardiac disorders 10013098 Disease coronary artery LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2011-000064-10 Sponsor Protocol Number: Fistula-SD-MD Start Date*: 2011-03-17
    Sponsor Name:Med. Univ. Wien, Klinik für klinische Pharmakologie
    Full Title: Target site pharmacokinetics of linezolid or tigecycline in patients with severe skin and skin structure infections (SSSI) associated with chronic fistulas.
    Medical condition: The findings of the present study will enable assessing whether currently employed therapy regimens with linezolid or tigecycline provide effective antimicrobial concentrations at the target site o...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2011-000062-35 Sponsor Protocol Number: ThereIsNoSponsorInvolved Start Date*: 2011-04-05
    Sponsor Name:Mikko Pitkänen, MD, PhD
    Full Title: Artikaiini 40mg ja kloroprokaiini 40 mg päiväkirurgisina spinaalipuudutteina (Lyhenne: A40C40)
    Medical condition: Knee arthroscopy performed as day case surgery
    Disease: Version SOC Term Classification Code Term Level
    12.1 10054948 Meniscus operation LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: View results
    EudraCT Number: 2019-002351-42 Sponsor Protocol Number: VIB4920.P0.S1 Start Date*: 2020-01-13
    Sponsor Name:Viela Bio, Inc.
    Full Title: An Observational, Follow-on Study to the MEDI4920 (D5100C00002) Study to Evaluate the Duration of Clinical and Pharmacodynamic Efficacy of 12 weeks of Treatment with VIB4920 in Subjects with Modera...
    Medical condition: Rheumatoid Arthritis
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004870 10039075 Rheumatoid arthritis and associated conditions HLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: PL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2015-003318-26 Sponsor Protocol Number: AS/NEPA/001 Start Date*: 2015-12-11
    Sponsor Name:ASSOCIAZIONE SALENTINA ANGELA SERRA ONLUS
    Full Title: Phase II, open-label, not comparative, multicenter study of multiple doses of NEPA (Netupitant+Palonosetron) in preventing chemotherapy induced nausea and vomiting (CINV) in patient with Non Hodgki...
    Medical condition: NON HODGKIN'S LYMPHOMA
    Disease: Version SOC Term Classification Code Term Level
    24.0 100000004864 10067070 Follicular B-cell non-Hodgkin's lymphoma LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2019-001807-19 Sponsor Protocol Number: TV50717-CNS-30081 Start Date*: 2019-11-12
    Sponsor Name:Teva Branded Pharmaceutical Products R&D, Inc.
    Full Title: An Open-Label, Long-Term Safety, Tolerability, and Efficacy Study of TEV-50717 (Deutetrabenazine) for the Treatment of Dyskinesia in Cerebral Palsy in Children and Adolescents (Open RECLAIM-DCP)
    Medical condition: Dyskinesia in cerebral palsy (DCP)
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004850 10068804 Athetoid cerebral palsy LLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: ES (Ongoing) PL (Prematurely Ended) DK (Completed) IT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2005-005292-15 Sponsor Protocol Number: H7T-MC-TABR & TABR (1) Start Date*: 2006-03-02
    Sponsor Name:Eli Lilly and Company Ltd.
    Full Title: A Pharmacokinetic and Pharmacodynamic Comparison of Prasugrel (LY640315) versus Clopidogrel in Subjects with Stable Atherosclerosis
    Medical condition: Stable atherosclerosis
    Disease: Version SOC Term Classification Code Term Level
    7.0 10011085 HLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: View results
    EudraCT Number: 2004-005142-12 Sponsor Protocol Number: TMC207-C203 Start Date*: 2005-06-25
    Sponsor Name:Tibotec Pharmaceuticals Limited
    Full Title: An open-label study to evaluate the extended early bactericidal activity, safety, tolerability and pharmacokinetics of multiple doses (m.d.) of TMC207 oral solution (os) and isoniazid (JH), m.d. of...
    Medical condition: Tuberculosis
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2011-005114-11 Sponsor Protocol Number: FO1 Start Date*: 2011-12-14
    Sponsor Name:AZIENDA USL DI FORLI'
    Full Title: Switching from clopidogrel to prasugrel to protect early invasive treatment in acute coronary syndromes
    Medical condition: Patients with acute coronary syndromes without persistent ST-segment elevation
    Disease: Version SOC Term Classification Code Term Level
    14.1 10007541 - Cardiac disorders 10051592 Acute coronary syndrome PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2015-001324-36 Sponsor Protocol Number: 1042-900 Start Date*: 2015-06-05
    Sponsor Name:Marinus Pharmaceuticals, Inc.
    Full Title: A Multicenter, Open-Label Proof-of-Concept Trial of Ganaxolone in Children with PCDH19 Female Pediatric Epilepsy
    Medical condition: PCDH19 Female Pediatric Epilepsy (FPE)
    Disease: Version SOC Term Classification Code Term Level
    18.0 100000004852 10032062 Other forms of epilepsy, with intractable epilepsy LLT
    Population Age: Children, Under 18 Gender: Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2018-003742-17 Sponsor Protocol Number: TV50717-CNS-30080 Start Date*: 2019-07-12
    Sponsor Name:Teva Branded Pharmaceutical Products R&D, Inc.
    Full Title: A Randomized, Double-Blind, Placebo-Controlled Study of TEV-50717 (Deutetrabenazine) for the Treatment of Dyskinesia in Cerebral Palsy in Children and Adolescents
    Medical condition: Dyskinesia in cerebral palsy (DCP)
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004850 10068804 Athetoid cerebral palsy LLT
    Population Age: Children, Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA) DK (Completed) PL (Completed) ES (Prematurely Ended) IT (Completed)
    Trial results: View results
    EudraCT Number: 2016-003491-41 Sponsor Protocol Number: AG-CLI-0206-LTFU Start Date*: 2016-12-12
    Sponsor Name:AnGes Inc.
    Full Title: A Long Term Follow-up Study of AMG0001 in Subjects with Critical Limb Ischemia
    Medical condition: Critical limb ischemia
    Disease: Version SOC Term Classification Code Term Level
    19.0 100000004866 10058069 Critical limb ischemia LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed) BE (Completed) FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2017-004433-93 Sponsor Protocol Number: RIOTCSTUDY22017 Start Date*: 2018-05-01
    Sponsor Name:Nicholas Stephen Macklon, Professor, MD, PhD
    Full Title: RIOT C: REDUCING THE IMPACT OF OVARIAN STIMULATION. NOVEL APPROACHES TO LUTEAL SUPPORT IN IVF. STUDY 2.
    Medical condition: Ovarian stimulation in oocyte donation
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004865 10071130 Controlled ovarian stimulation LLT
    20.0 100000004869 10072100 Egg donor LLT
    Population Age: Adults Gender: Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2014-004849-26 Sponsor Protocol Number: Parachute04 Start Date*: 2015-02-05
    Sponsor Name:UMC Utrecht
    Full Title: PARACHUTE-trial Prospective Analysis of an individualized dosing Regimen of ATG (Thymoglobulin) in Children Undergoing HCT: redUcing Toxicity and improving Efficacy – a single arm phase II study
    Medical condition: Leukemia and immunedeficiency syndromes
    Disease: Version SOC Term Classification Code Term Level
    20.0 10021428 - Immune system disorders 10021428 Immune system disorders SOC
    20.1 100000004864 10024329 Leukemia LLT
    Population Age: Adolescents, Under 18 Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: View results
    EudraCT Number: 2011-003628-11 Sponsor Protocol Number: TapOxy001 Start Date*: 2011-10-26
    Sponsor Name:University Hospital Schleswig Holstein Kiel, Clinic of Neurology
    Full Title: Tapentadol PR vs Oxycodon CR A pilotstudiy for a mechanism-orientated Therapy of peripheral chronic neuropathic pain syndrom
    Medical condition: Chronical neuropathic pain syndrome
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2021-001080-24 Sponsor Protocol Number: NL76906.068.21 Start Date*: 2021-04-08
    Sponsor Name:Maastricht University
    Full Title: The effect of plant stanol ester consumption on the vaccination response to a COVID-19 vaccine
    Medical condition: COVID-19 vaccination respons of people with BMI 27-35 kg/m2
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Prematurely Ended)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Fri May 30 10:47:09 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA